AstraZeneca Buys CinCor in a Deal Worth Up to $1.8B

AstraZeneca Buys CinCor in a Deal Worth Up to $1.8B

Submitted by admin on January 9, 2023 - 10:41am
Source: 
BioSpace
News Tags: 
AstraZeneca
CinCor Pharma
M&A
Headline: 
AstraZeneca Buys CinCor in a Deal Worth Up to $1.8B
snippet: 

AstraZeneca has inked a definitive agreement to acquire cardiorenal disease player CinCor Pharma in a deal that could potentially reach $1.8 billion in total value, the companies announced Monday.

Do Not Allow Advertisers to Use My Personal information